General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chiba T et al. – The three cases have been receiving ongoing infliximab maintenance therapy and are currently symptom–free. Infliximab thus appears to be useful for treatment of gastrointestinal bleeding in CD patients.

Related Articles

A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09    Relevance Score: 69%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09    Relevance Score: 68%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09    Relevance Score: 68%

Bowel Disease Treatment May Raise Skin Cancer Risk
MedLinePlus, 10/28/09    Relevance Score: 68%

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09    Relevance Score: 68%

Today in Endoscopy...keeping you current

Confocal laser endomicroscopy in the "in vivo" histological diagnosis of the gastrointestinal tract
World Journal of Gastroenterology, 12/15/09

Endoscopic Nodular Gastritis in Dyspeptic Adults: Prevalence and Association with Helicobacter pylori Infection
Medical Principles and Practice, 12/15/09

Asymmetric endoscopic inflammation of the ileal pouch: A sign of ischemic pouchitis
Inflammatory Bowel Disease, 12/14/09

Today in Inflammatory Bowel Dz...keeping you current

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09

Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease
World Journal of Gastroenterology, 12/15/09

Protection of Epithelial Barrier Function by the Crohn's Disease Associated Gene Protein Tyrosine Phosphatase N2
Gastroenterology, 12/14/09

Today in Pharmacology/kinetics...keeping you current

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09

Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09

Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address